Literature DB >> 16140241

Which clinical conditions are responsible for impaired alertness?

Michael J Thorpy1.   

Abstract

The complaint of excessive daytime sleepiness, commonly encountered in clinical practice, may arise from many medical and psychiatric disorders and behavioural lifestyle changes. The list of possibilities spans virtually every major area of medicine, neurology and psychiatry. Assessment of impaired alertness is largely based on clinical interview and direct observation, but it may also include subjective self-report, objective physiological and behavioural measures, and performance tests. In the primary care setting, a clear and detailed history is invaluable in negotiating these numerous diagnostic considerations. Primary care physicians need to be aware that the patient's complaint may be expressed in terms of 'tiredness' or 'fatigue' rather than a direct reference to impaired alertness or performance. Accurate diagnosis is important, not only because of the negative impact of impaired alertness and its possible underlying causes on health and the quality of the patient's professional and social life, but also because impaired alertness due to poor sleep quality can be remedied with appropriate treatment. Increased understanding of the neurological basis of alertness and sleepiness will undoubtedly lead to improved treatments. To facilitate improved understanding of the symptoms, aetiology, pathophysiology and treatment of impaired alertness, classification of the sleep disorders is necessary to discriminate between disorders. Based on recent advances in knowledge about sleep disorders, the recently published second version of the International Classification of Sleep Disorders (ICSD) has been expanded to include 85 sleep disorders under eight major categories: (1) insomnias, (2) sleep-related breathing disorders, (3) hypersomnias not due to a breathing disorder, (4) circadian rhythm sleep disorders, (5) parasomnias, (6) sleep-related movement disorders, (7) other sleep disorders, and (8) isolated symptoms, apparently due to adverse effect of drugs, medications and biological substances. The ICSD provides relevant information on the diagnostic features and epidemiology to differentiate between sleep disorders, and it will no doubt serve as a core resource in the development of recommendations for primary care physicians to guide the diagnosis and treatment of patients with impaired alertness.

Entities:  

Mesh:

Year:  2005        PMID: 16140241     DOI: 10.1016/s1389-9457(05)80004-8

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  8 in total

1.  The assessment, diagnosis, and treatment of excessive sleepiness: practical considerations for the psychiatrist.

Authors:  Dewey McWhirter; Charles Bae; Kumaraswamy Budur
Journal:  Psychiatry (Edgmont)       Date:  2007-09

2.  Insulinoma presenting as idiopathic hypersomnia.

Authors:  Michelangelo Maestri; Fabio Monzani; Enrica Bonanni; Elisa Di Coscio; Fabio Cignoni; Angela Dardano; Alfonso Iudice; Luigi Murri
Journal:  Neurol Sci       Date:  2010-01-30       Impact factor: 3.307

3.  Evaluation of the safety of modafinil for treatment of excessive sleepiness.

Authors:  Thomas Roth; Jonathan R L Schwartz; Max Hirshkowitz; Milton K Erman; Jeffrey M Dayno; Sanjay Arora
Journal:  J Clin Sleep Med       Date:  2007-10-15       Impact factor: 4.062

4.  Recognition and management of excessive sleepiness in the primary care setting.

Authors:  Jonathan R L Schwartz; Thomas Roth; Max Hirshkowitz; Kenneth P Wright
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

5.  Improvement in Fatigue, Sleepiness, and Health-Related Quality of Life with Bright Light Treatment in Persons with Seasonal Affective Disorder and Subsyndromal SAD.

Authors:  Cecilia Rastad; Jan Ulfberg; Per Lindberg
Journal:  Depress Res Treat       Date:  2011-06-13

6.  The Revised Mood Rhythm Instrument: A Large Multicultural Psychometric Study.

Authors:  Melissa Alves Braga de Oliveira; Euclides José de Mendonça Filho; Alicia Carissimi; Luciene Lima Dos Santos Garay; Marina Scop; Denise Ruschel Bandeira; Felipe Gutiérrez Carvalho; Salina Mathur; Kristina Epifano; Ana Adan; Benicio N Frey; Maria Paz Hidalgo
Journal:  J Clin Med       Date:  2021-01-20       Impact factor: 4.241

7.  Clinical pharmacology in sleep medicine.

Authors:  Ashley Proctor; Matt T Bianchi
Journal:  ISRN Pharmacol       Date:  2012-11-14

8.  Sleep disturbances in an arctic population: the Tromsø Study.

Authors:  Arne Fetveit; Jørund Straand; Bjørn Bjorvatn
Journal:  BMC Health Serv Res       Date:  2008-05-29       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.